Strategic Collaborations

Strategic collaborations and partnerships with the Best of Class.

early stage cancer detection - BioMark Diagnostics we believe cancer can be cured
early stage cancer detection - BioMark Diagnostics we believe cancer can be cured

Parternships and Collaborations

BioMark's Strategic Collaborations

BioMark is pleased to have created partnerships and strategic collaborations with some of North America’s leading facilities, laboratories, and Universities.

CancerCare Manitoba is the provincially mandated cancer agency tasked with providing cancer services to the people of Manitoba.

University of Maryland School of Medicine

University of Manitoba

First there was the St. Boniface Hospital, then the St. Boniface Hospital Foundation

The Metabolomics Innovation Centre

University of British Columbia

MEDTEQ, Innovation for Health

CancerCare Manitoba & Manitoba Tumor Bank

University of Victoria

Biopharmaceutical Research Inc.

National Cancer Research Institute in Bangladesh

Institut Universitaire de Cardiologie et de Pneumologie de Quebec (ICUPQ)

University of Laval

CHTN - Cooperative Human Tissue Network

University of Brescia

Optonique

Quebec International

McMaster University

Are you looking to establish strategic collaboration or partnership opportunity in cancer research or early stage cancer detection with an innovative and progressive research company?  We are interested in collaborations with leading researchers, institutions, and facilities with proven track records.  Contact us at [email protected] 

Sign up for the latest Biomark news

No paperwork, no hassle. We keep things digital, easy and regular.

*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.

early stage cancer detection - BioMark Diagnostics we believe cancer can be cured
early stage cancer detection - BioMark Diagnostics we believe cancer can be cured

© 2021 BioMark Diagnostics Inc. All Rights Reserved. BioMark’s mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.